Company / Current Assets
ResMed Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.5B
FY2025
5-year range
$1.6B / $3.5B
FY2021-FY2025
Trend
+48.7%
vs FY2024
Sector context
#35 of 165
Health Care
What the data says
ResMed's current assets of $3.5B is higher than 79% of companies in the Health Care sector (FY2025). Current Assets has fluctuated over the past 10 years, ranging from $1.1B in FY2018 to $3.5B in FY2025.
Based on SEC 10-K filings.
$3.5B in FY2025 with a 5-year CAGR of +18.1%. Top quartile in the Health Care sector.
Improved from $2.4B to $3.5B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +22.0%
- 5-Year CAGR
- +18.1%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 165This company $3.5B Sector average $5.2B
▼
-33.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.1%, indicating consistent growth.
- In FY2025, current assets increased 48.7% year-over-year.
- Ranks #35 out of 165 companies in the Health Care sector.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5B | +48.7% |
| FY2024 | $2.4B | -0.4% |
| FY2023 | $2.4B | +22.6% |
| FY2022 | $1.9B | +22.7% |
| FY2021 | $1.6B | +3.4% |
| FY2020 | $1.5B | +33.0% |
| FY2019 | $1.1B | +7.5% |
| FY2018 | $1.1B | -35.2% |
| FY2017 | $1.6B | +15.8% |
| FY2016 | $1.4B | +0.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026